Search hospitals > Nevada > Reno
Center of Hope at Renown Medical Center
Claim this profileReno, Nevada 89502
Global Leader in Ovarian Cancer
Global Leader in Ovarian Tumors
Conducts research for Fallopian Tube Cancer
Conducts research for Cancer
Conducts research for Serous Cystadenocarcinoma
39 reported clinical trials
1 medical researcher
Summary
Center of Hope at Renown Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Ovarian Cancer, Ovarian Tumors, Fallopian Tube Cancer, Cancer, Serous Cystadenocarcinoma and other specialties. Center of Hope at Renown Medical Center is involved with conducting 39 clinical trials across 88 conditions. There are 1 research doctors associated with this hospital, such as Peter Lim.Area of expertise
1Ovarian Cancer
Global LeaderFRα positive
Stage III
Stage IV
2Ovarian Tumors
Global LeaderFRα positive
Stage III
Stage IV
Top PIs
Clinical Trials running at Center of Hope at Renown Medical Center
Ovarian Cancer
Fallopian Tube Cancer
Ovarian Tumors
Endometrial Cancer
Cervical Cancer
Adenomyoepithelioma
Clear Cell Adenocarcinoma
Ovarian Carcinoma
Peritoneal Cancer
Peritoneal Carcinoma
Olvi-Vec + Chemotherapy
for Ovarian Cancer
The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer). This Phase III trial builds on the efficacy and safety data reported in the previous Phase II VIRO-15 trial with promising objective response rate and progression-free survival observed in heavily pre-treated patients with platinum-resistant/refractory ovarian cancer. The phase II results also showed that the intra-peritoneal route of delivery was efficient in generating tumor cell killing and immune activation, and led to clinical reversal of platinum-resistance or refractoriness in this difficult-to-treat patient population.
Recruiting2 awards Phase 313 criteria
ONC-392 + Pembrolizumab
for Ovarian Cancer
This is a study to test the safety and efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian cancer patients.
Recruiting2 awards Phase 212 criteria
Mirvetuximab + Bevacizumab
for Ovarian Cancer
GLORIOSA is a Phase 3 multicenter, open label study designed to evaluate the safety and efficacy of mirvetuximab Soravtansine as maintenance therapy in participants with platinum-sensitive ovarian, primary peritoneal or fallopian tube cancers with high folate receptor-alpha (FRα) expression.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Center of Hope at Renown Medical Center?
Center of Hope at Renown Medical Center is a medical facility located in Reno, Nevada. This center is recognized for care of Ovarian Cancer, Ovarian Tumors, Fallopian Tube Cancer, Cancer, Serous Cystadenocarcinoma and other specialties. Center of Hope at Renown Medical Center is involved with conducting 39 clinical trials across 88 conditions. There are 1 research doctors associated with this hospital, such as Peter Lim.